Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Geron Corporation
Geron Corp is a biopharmaceutical company. It supports the clinical stage development of a telomerase inhibitor, imetelstat.
IPO Date: July 31, 1996
Sector: Healthcare
Industry: Biotech
Market Cap: $802.52M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.11 | 2.89%
Avg Daily Range (30 D): $0.05 | 3.20%
Avg Daily Range (90 D): $0.05 | 3.64%
Institutional Daily Volume
Avg Daily Volume: 2.76M
Avg Daily Volume (30 D): 7.81M
Avg Daily Volume (90 D): 10.18M
Trade Size
Avg Trade Size (Sh.): 343
Avg Trade Size (Sh.) (30 D): 491
Avg Trade Size (Sh.) (90 D): 511
Institutional Trades
Total Inst.Trades: 2,640
Avg Inst. Trade: $1.87M
Avg Inst. Trade (30 D): $1.27M
Avg Inst. Trade (90 D): $1.37M
Avg Inst. Trade Volume: .61M
Avg Inst. Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $2.36M
Avg Closing Trade (30 D): $1.25M
Avg Closing Trade (90 D): $1.43M
Avg Closing Volume: 812.4K
   
News
May 12, 2025 @ 1:54 PM
GERN Investors are Reminded of an Opportunity to L...
Source: Prnewswire
May 11, 2025 @ 12:17 PM
Faruqi & Faruqi Reminds Geron Investors of the Pen...
Source: N/A
May 9, 2025 @ 1:00 PM
INVESTOR ALERT: Pomerantz Law Firm Investigates Cl...
Source: Pomerantz Llp
May 9, 2025 @ 12:00 PM
INVESTOR ALERT: Pomerantz Law Firm Announces the F...
Source: N/A
May 7, 2025 @ 8:35 PM
Why Geron Stock Crept Higher Today
Source: Eric Volkman
Financials
  TTM Q1 2025 Q4 2024
Basic EPS $-.21 $-.03 $-.04
Diluted EPS $-.21 $-.03 $-.04
Revenue $ 116.29M $ 39.6M $ 47.54M
Gross Profit $ $ $
Net Income / Loss $ -139.02M $ -19.84M $ -25.35M
Operating Income / Loss $ -134.3M $ -16.7M $ -20.05M
Cost of Revenue $ $ $
Net Cash Flow $ -105.26M $ 4.73M $ 18.71M
PE Ratio